IP Library › Granted Patent US 10,384,372
Granted Patent B2
US 10,384,372 · App. 14/782,459 · Granted Aug 20, 2019

Method for producing shaped polymeric microparticles

Inventors: Raffaele Vecchione (Naples, IT); Renato De Alteriis (Naples, IT); Paolo Antonio Netti (Naples, IT)
Assignee: Fondazione Istituto Italiano di Tecnologia
B29B9/12B29B9/16B29B2009/125B29B2009/166B29K2067/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,384,372
App. No.
14/782,459
Granted
Aug 20, 2019
Kind
B2
Abstract

Method for producing shaped polymeric microparticles of non-spherical shape, comprising the steps of: placing one or more microparticles of substantially spherical shape in a respective micro-cavity of a mold having the desired non-spherical shape; subjecting said microparticles to softening by exposure to a solvent or mixture of solvent/non-solvent, in the liquid or vapor state, adapted to plasticize the polymeric material constituting said microparticles, and possibly assisting the solvent plasticization process by heat treatment, not excluding the possibility, in less critical cases in terms of conservation of the microstructure, of carrying out heat treatment exclusively, at a temperature not exceeding 40% of the glass transition temperature of the polymer material; and removing said microparticles from the mold cavities.

Claims (13)

1. Method for producing non-spherical polymeric microparticles having a microporous structure, comprising the steps of:

providing a plurality of polymeric microparticles, each microparticle having a microporous structure and having a substantially spherical shape filled with a drug or a biomolecule;

placing each microparticle in a respective micro-cavity of a mould comprised of multiple non-spherical shaped micro-cavities;

softening each microparticle by exposure to a solvent or mixture of solvent and non-solvent, in a vapour state at a temperature below 60° C. or exclusively by heat treatment at a temperature not exceeding 40% above the glass transition temperature thereby plasticizing the polymeric material constituting said microparticle;

consolidating the thus obtained plasticized microparticle, and

removing each plasticized non-spherical microparticle from the respective mould micro-cavity, wherein the said plasticized non-spherical microparticle has maintained said microporous structure;

whereby degradation of said drug or biomolecule in said plasticized non-spherical microparticle is avoided.

2. Method according to claim 1 , comprising the step of subjecting said microparticles to a pressure in the respective mould micro-cavities prior to removal from said mould micro-cavity.

3. Method according to claim 1 , characterized in that the softening of the particles is caused by localized application in the mould micro-cavity of a solvent or a mixture of solvent and non-solvent in a vapour state, at a temperature below 40° C.

4. Method according to claim 1 for deforming microparticles having a size from 2 μm to 600 μm in diameter.

5. Method according to claim 1 , wherein said micro-cavities have a base with a structured surface such that the shaped microparticles have a corresponding surface structure.

6. Method according to claim 1 , wherein said shaped microparticles are formed by a biodegradable or biocompatible thermoplastic polymer.

7. Method according to claim 1 , wherein said shaped microparticles comprise polylactic acid) (PLA), polylactic-co-glycolic acid) (PLGA), polycaprolactone (PCL) or gelatine.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2015
From: VECCHIONE, RAFFAELE; DE ALTERIIS, RENATO; NETTI, PAOLO ANTONIO
To: FONDAZIONE ISTITUTO ITALIANO DI TECHNOLOGIA
Reel/Frame 036784/0730 →
Priority Claims (1)
IT TO2013A0284 · Apr 9, 2013 · national
Continuity (1)
Related Publication 20160039117A1 · Feb 11, 2016
Cited By (2)
US 12,390,537 US 12,622,963